Metabolic Switch in the Tumor Microenvironment Determines Immune Responses to Anti-cancer Therapy

Frontiers in Oncology
Barbara WegielPankaj Seth

Abstract

Tumor-induced immune tolerance permits growth and spread of malignant cells. Cancer cells have strong influence on surrounding cells and shape the hypoxic tumor microenvironment (TME) facilitating cancer progression. A dynamic change in glucose metabolism occurring in cancer cells and its influence on the TME are still poorly understood. Indeed, cancer and/or immune cells undergo rapid adaptation in metabolic pathways during cancer progression. Metabolic reprograming affects macrophages, T cells, and myeloid derived suppressor cells (MDSCs) among other immune cells. Their role in the TME depends on a nature and concentration of factors, such as cytokines, reactive oxygen species (ROS), growth factors, and most importantly, diffusible metabolites (i.e., lactate). Further, the amounts of available nutrients and oxygen as well as activity of microbiota may influence metabolic pathways in the TME. The roles of metabolites in regulating of the interaction between immune and cancer cell are highlighted in this review. Targeting metabolic reprogramming or signaling pathways controlling cell metabolism in the TME might be a potential strategy for anti-cancer therapy alone or in combination with current immunotherapies.

References

May 4, 1999·The Journal of Experimental Medicine·D H MunnA L Mellor
May 8, 2000·Journal of Applied Physiology·N S Chandel, P T Schumacker
Jul 4, 2003·The Journal of Nutrition·James R Davie
Sep 18, 2003·Nature Reviews. Cancer·Gregg L Semenza
Feb 24, 1956·Science·O WARBURG
Mar 17, 2004·Cancer Treatment Reviews·Juan Angel Fresno VaraManuel González-Barón
Apr 3, 2004·Cancer Research·Fabiana Schwartzenberg-Bar-YosephEddy Karnieli
Nov 18, 2004·Journal of the National Cancer Institute·Francesca LucianiStefano Fais
Mar 8, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Antonio SicaPaola Allavena
Jul 15, 2006·Cell·Karim BensaadKaren H Vousden
Sep 13, 2006·Cancer Metastasis Reviews·Alberto MantovaniAntonio Sica
Jan 11, 2007·Cancer Research·Dmitry I GabrilovichHans Schreiber
Jan 27, 2007·Blood·Karin FischerMarina Kreutz
Jun 7, 2007·Journal of Bioenergetics and Biomembranes·Gregg L Semenza
Mar 26, 2008·Nature·Francisco J QuintanaHoward L Weiner
May 2, 2008·Cancer Letters·Antonio SicaAlberto Mantovani
Jun 10, 2008·Cancer Cell·Guido Kroemer, Jacques Pouyssegur
Dec 26, 2008·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Henrike M HamerRobert-Jan M Brummer
Aug 20, 2009·Mini Reviews in Medicinal Chemistry·Alvaro Marín-HernándezRafael Moreno-Sánchez
Jan 19, 2010·Carcinogenesis·María Sánchez-AragóJosé M Cuezva
Mar 31, 2010·Proceedings of the National Academy of Sciences of the United States of America·Sawako SuzukiCarol Prives
Apr 9, 2010·Future Oncology·Richard FlavinMassimo Loda
Jun 24, 2010·Trends in Biochemical Sciences·David R Wise, Craig B Thompson
Aug 20, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Joshua D MezrichChristopher A Bradfield
Sep 30, 2010·The Journal of Experimental Medicine·Cesar A CorzoDmitry I Gabrilovich
Feb 15, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ryan D MichalekJeffrey C Rathmell
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
May 31, 2011·Cancer Biology & Therapy·Chuigong YuLibo Yao
Jun 29, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Moniek HeusinkveldSjoerd H van der Burg
Sep 8, 2011·International Journal of Cancer. Journal International Du Cancer·Anna N MendlerElfriede Noessner
Oct 7, 2011·Nature·Christiane A OpitzMichael Platten
Nov 1, 2011·Nature Medicine·Kristin M NiemanErnst Lengyel
Nov 2, 2011·Proceedings of the National Academy of Sciences of the United States of America·Ryan D MichalekJeffrey C Rathmell
Mar 23, 2012·Nature Reviews. Immunology·Dmitry I GabrilovichVincenzo Bronte
Mar 24, 2012·Cancer Cell·Patrick S Ward, Craig B Thompson
Jun 16, 2012·The Journal of Pharmacology and Experimental Therapeutics·Eduardo N Maldonado, John J Lemasters
Aug 14, 2012·Biochemical and Biophysical Research Communications·Ines HammamiMario Jolicoeur

❮ Previous
Next ❯

Citations

Sep 11, 2019·Cells·Hung-Chi YangDaniel Tsun-Yee Chiu
Dec 17, 2019·Antioxidants & Redox Signaling·Natalie Y L NgoiAndrea L A Wong
Oct 31, 2019·International Journal of Molecular Sciences·Nicole Bezuidenhout, Maria Shoshan
Mar 12, 2020·Immunotherapy·Amrita Basu, Krithika Kodumudi
Jun 15, 2019·Pleura and Peritoneum·Robert B WilsonMarc A Reymond
Jun 26, 2020·Frontiers in Cell and Developmental Biology·Linda Anna Michelle KulkaHeidi Olzscha
Mar 27, 2020·Frontiers in Oncology·Xiaoping LinHuiqin Guo
Oct 6, 2020·Frontiers in Endocrinology·Eline Constance Brombacher, Bart Everts
Feb 3, 2019·Cells·Charlotte DomblidesBenjamin Faustin
Jul 1, 2020·Cancers·Sabina SanegreTomás Álvaro Naranjo
Jun 7, 2020·Journal of Hematology & Oncology·Wenyu WangYong Sang Song
Jan 19, 2020·Trends in Cancer·Shawn McGuirkJulie St-Pierre
Mar 16, 2021·Critical Reviews in Oncology/hematology·RamaRao MallaGanji Purnachandra Nagaraju
Dec 23, 2020·Analytical Biochemistry·Thambi DoraiArthur J L Cooper
May 15, 2021·Journal for Immunotherapy of Cancer·Dan P ZandbergGreg M Delgoffe
Aug 11, 2021·Molecules and Cells·Peter Karagiannis, Shin-Il Kim
Oct 31, 2021·Journal of Translational Medicine·Taiana Campos LeiteGiuseppe Intini
Nov 19, 2021·Bioconjugate Chemistry·Ayesha ZafarZhifei Dai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cellular Immunometabolism

Immunometabolism involves not only the way metabolites are digested by the immune system, but the way in which they can alter the pathway of the immune system. These responses occur in day-to-day healthy cell functioning, but can result in diseases, such as autoimmune disorders. Discover the latest research on cellular immunometabolism here.

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.